{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreietjzjmbk4yky53wzf63nupxs4ywkd5avddz552xp5vwdgjj7c6cq",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mkqgdfvvrsn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie2xo22udw4bovedy7xpsik6nf5slkpa4oehy6j4s6lnlxdnawufe"
    },
    "mimeType": "image/jpeg",
    "size": 143715
  },
  "path": "/the-hidden-risk-of-taking-breaks-from-weight-loss-drugs-like-ozempic/",
  "publishedAt": "2026-04-30T18:12:07.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Endocrinology",
    "Metabolism",
    "Obesity",
    "Pharmaceuticals",
    "Semaglutide",
    "University of Pennsylvania"
  ],
  "textContent": "A new study suggests that the effectiveness of widely used GLP-1 weight-loss drugs may depend strongly on consistent use. Intermittently stopping and restarting popular GLP-1 weight loss drugs such as Ozempic and Wegovy may weaken their impact over time, according to new research from the Perelman School of Medicine at the University of Pennsylvania. In [...]",
  "title": "The Hidden Risk of Taking Breaks From Weight-Loss Drugs Like Ozempic"
}